Pneumonia Diagnostics Market: North America Projected to be the Most Lucrative Regional Market During the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027
- REP-GB-2970
- 2017-11-07
- Category: Healthcare, Pharmaceuticals and Medical devices
- 168 Pages
- Format:
Greater Adoption of Pneumonia Diagnostics Equipment Worldwide
A paradigm shift has been observed from traditional culture diagnosis to rapid pneumonia identification - a game-changer in the pneumonia diagnostics market. In the traditional method, cultures are used to detect pneumonia causative organisms. This is a time-consuming process with a higher error rate when compared to rapid diagnostics. In a few cases such as legionella, culture identification is not readily available and this increases the mortality rate of pneumonia cases caused by it. The rapid rate of technological advancement has made pneumonia diagnosis much quicker and more cost-effective with a greater degree of sensitivity and specificity. The urinary antigen is an extremely-effective rapid test that allows targeted therapy foe legionnaire at the point-of-care itself.
Diagnostic Difficulties Pose a Challenge in Pneumonia Diagnostics Market
It is typically not difficult to diagnose and manage pneumonia in a community seating. Clinical decisions are mainly used in diagnosis information. Nonetheless, there have been some cases with fake positive results that have led to serious patient mismanagement. The patients were prescribed antibiotics and reported super infections and complications because of the former. Immunoassay techniques seem to be fairly promising for pneumonia diagnostics but are inadequate currently to screen a diverse array of organisms. All of these factors can restrict the growth of the pneumonia diagnostics market and can even decrease adoption in certain situations.
Demand for Rapid Diagnostics Tests Trending the Pneumonia Diagnostics Market
On account of a rising number of patients contracting pneumonia, the demand for high-quality rapid test kits has seen a noticeable spike. Kits that are fast-acting, have high sensitivity, and specificity is quite high from physicians, hospitals, and diagnostics labs across the world. In addition to this, there is also demand for cost-effective diagnostic kits, particularly in European nations that demand cheaper kits, affluence and higher disposable income notwithstanding.
North America Largest Region in the Global Pneumonia Diagnostics Market
North America has the largest market share in the pneumonia diagnostics market and should remain so for the duration of the forecast period. The US accounts for more than 4/5th of the North America pneumonia diagnostics market and represents a much larger opportunity than its larger neighbour. However, it would be unwise to ignore Canada entirely as it is poised to witness a higher CAGR of 6.4% for the decade. The intense competition in the North America pneumonia diagnostics market is predicted to cause pricing pressure and key stakeholders will have to take this into account.
UK and Germany Critical in Western Europe Pneumonia Diagnostics Market
The UK and Germany accounted for more than 2/5th of the Western Europe pneumonia diagnostics market primarily because of their robust, well-developed healthcare infrastructure and a greater awareness of a geriatric population likely to develop such health issues. The streptococcus-based product type holds the key to success in the Western Europe pneumonia diagnostics market and companies are recommended to devise their market strategies accordingly. The Western Europe pneumonia diagnostics market is on track to be worth almost US$ 147 million by end 2027.
APEJ Closely Follows Western Europe in Global Pneumonia Diagnostics Market
APEJ is the third largest region in the pneumonia diagnostics market behind North America and Europe but is unlikely to cross the latter for the foreseeable future. China and India are the countries to keep an eye out for in the APEJ pneumonia diagnostics market. The China pneumonia diagnostics market has a value of approx. US$ 16 million in 2017 itself.
Global Report with Exhaustive Focus on Emerging and Developed Regions
Future Market Insights provides a forecast of the global pneumonia diagnostics market in terms of value from 2017 to 2027. The study is an in-depth illustration of the trends and dynamics witnessed across the seven regions viz. Western Europe, Eastern Europe, North America, APEJ, Japan, and Latin America that impact current and future prospects in the global pneumonia diagnostics market.
Well-laid Out, Logical, Cohesive Report Structure
The research report includes a comprehensive assessment of the global pneumonia diagnostics market and delivers insights into the different factors contributing to the popularity of pneumonia diagnostics equipment. The report offers an analysis of important drivers, restraints, opportunities, and trends that shape the pneumonia diagnostics market along with an evaluation of stakeholder strategies to achieve success in the pneumonia diagnostics market. The report begins with an overview of the pneumonia diagnostics market that caters to a global audience by mentioning revenue figures in US dollars. Furthermore, the section comprises an analysis of all relevant factors from the demand and supply side that influence the pneumonia diagnostics market with a segmental break-down across all the studied regions.
Pneumonia Diagnostics Market Taxonomy
|
Product Type |
Region |
|---|---|
|
|
A critical section of the report highlights the pneumonia diagnostics market across the regions. The market outlook is for the decade from 2017 to 2027 and mentions the forecast within the aforementioned period, including the latest technological developments coupled with new products available in the pneumonia diagnostics market. Region and country-specific trends are focused on at great length in the report and an investigation of these drivers is par for the course. The report takes into account the present and future scenario of the pneumonia diagnostics market by considering 2016 as the base year with all the requisite data provided for the readers’ benefit. For an accurate forecast, the current market is sized up to form the basis of predicting the future potential in the pneumonia diagnostics market.
The concluding section of the report consists of a competition dashboard that provides a holistic view of the pneumonia diagnostics market. The dashboard is in an easy-to-understand format and has a company overview, product portfolio, financials, strategies adopted, and recent developments in the pneumonia diagnostics market. This section makes it possible to make a detailed and objective assessment of key stakeholders in specific market segments of the pneumonia diagnostics market. Competitors can be identified based on their capabilities and success in the pneumonia diagnostics market and profiles go a long way in determining the strategies adopted by them to strengthen their competitive position in the pneumonia diagnostics market.
Fool-Proof, Robust Research Methodology
The research methodology devised by Future Market Insights is an industry leading one that is trusted by clients as an authoritative source on the pneumonia diagnostics market. Our team of experts have years of experience in the healthcare domain and begin their study with a winning combination of primary and secondary research to gain an initial understanding of the market. Forecasts are conducted not only in terms of CAGR but also with parameters such as Y-o-Y growth to gauge market predictability and tap the opportunities as they arise. The report undergoes several channels of validation and cross-verification to ensure accuracy to the highest standard and only trusted sources such as company releases, government websites, and industry journals are used to gather the necessary qualitative and quantitative insights.
Pneumonia Diagnostic Market Reports - Table of Contents
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Pneumonia Diagnostics Market View Point
3.1. Macro-Economic Factors
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Trends
3.3. Opportunity Analysis
3.4. Epidemiology of Pneumonia & Leading Causes of Pneumonia
4. North America Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027
4.1. Introduction
4.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
4.2.1. U.S.
4.2.2. Canada
4.3. Market Size (US$ Mn) Forecast By Country, 2017-2027
4.3.1. U.S.
4.3.2. Canada
4.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
4.4.1. Streptococcus based
4.4.2. Legionella based
4.4.3. Chlamydophila based
4.4.4. Mycoplasma Pneumonia based
4.4.5. Viral Pneumonia based
4.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
4.5.1. Streptococcus based
4.5.2. Legionella based
4.5.3. Chlamydophila based
4.5.4. Mycoplasma Pneumonia based
4.5.5. Viral Pneumonia based
4.6. Drivers and Restraints: Impact Analysis
4.7. Market Attractiveness Analysis
4.7.1. By Country
4.7.2. By Product Type
4.8. Key Representative Market Participants
4.9. Key Participants Market Presence (Intensity Map)
5. Western Europe Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027
5.1. Introduction
5.2. Historical Market Size (US$ Mn) and Volume Analysis By Country, 2012-2016
5.2.1. Germany
5.2.2. United Kingdom
5.2.3. France
5.2.4. Italy
5.2.5. Spain
5.2.6. Nordics
5.2.7. Rest of Western Europe
5.3. Market Size (US$ Mn) and Volume Forecast By Country, 2017-2027
5.3.1. Germany
5.3.2. United Kingdom
5.3.3. France
5.3.4. Italy
5.3.5. Spain
5.3.6. Nordics
5.3.7. Rest of Western Europe
5.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
5.4.1. Streptococcus based
5.4.2. Legionella based
5.4.3. Chlamydophila based
5.4.4. Mycoplasma Pneumonia based
5.4.5. Viral Pneumonia based
5.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
5.5.1. Streptococcus based
5.5.2. Legionella based
5.5.3. Chlamydophila based
5.5.4. Mycoplasma Pneumonia based
5.5.5. Viral Pneumonia based
5.6. Drivers and Restraints: Impact Analysis
5.7. Market Attractiveness Analysis
5.7.1. By Country
5.7.2. By Product Type
5.8. Key Representative Market Participants
5.9. Key Participants Market Presence (Intensity Map)
6. Eastern Europe Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027
6.1. Introduction
6.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
6.2.1. Russia
6.2.2. Poland
6.2.3. Rest of Eastern Europe
6.3. Market Size (US$ Mn) Forecast By Country, 2017-2027
6.3.1. Russia
6.3.2. Poland
6.3.3. Rest of Eastern Europe
6.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
6.4.1. Streptococcus based
6.4.2. Legionella based
6.4.3. Chlamydophila based
6.4.4. Mycoplasma Pneumonia based
6.4.5. Viral Pneumonia based
6.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
6.5.1. Streptococcus based
6.5.2. Legionella based
6.5.3. Chlamydophila based
6.5.4. Mycoplasma Pneumonia based
6.5.5. Viral Pneumonia based
6.6. Drivers and Restraints: Impact Analysis
6.7. Market Attractiveness Analysis
6.7.1. By Country
6.7.2. By Product Type
6.8. Key Representative Market Participants
6.9. Key Participants Market Presence (Intensity Map)
7. Latin America Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Market Size (US$ Mn) Forecast By Country, 2017-2027
7.3.1. Brazil
7.3.2. Mexico
7.3.3. Rest of Latin America
7.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
7.4.1. Streptococcus based
7.4.2. Legionella based
7.4.3. Chlamydophila based
7.4.4. Mycoplasma Pneumonia based
7.4.5. Viral Pneumonia based
7.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
7.5.1. Streptococcus based
7.5.2. Legionella based
7.5.3. Chlamydophila based
7.5.4. Mycoplasma Pneumonia based
7.5.5. Viral Pneumonia based
7.6. Drivers and Restraints: Impact Analysis
7.7. Market Attractiveness Analysis
7.7.1. By Country
7.7.2. By Product Type
7.8. Key Representative Market Participants
7.9. Key Participants Market Presence (Intensity Map)
8. Japan Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027
8.1. Introduction
8.2. Regional Market Dynamics
8.2.1. Drivers
8.2.2. Restraints
8.2.3. Trends
8.3. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
8.3.1. Streptococcus based
8.3.2. Legionella based
8.3.3. Chlamydophila based
8.3.4. Mycoplasma Pneumonia based
8.3.5. Viral Pneumonia based
8.4. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
8.4.1. Streptococcus based
8.4.2. Legionella based
8.4.3. Chlamydophila based
8.4.4. Mycoplasma Pneumonia based
8.4.5. Viral Pneumonia based
8.5. Drivers and Restraints: Impact Analysis
8.6. Market Attractiveness Analysis
8.6.1. By Product Type
8.7. Key Representative Market Participants
8.8. Key Participants Market Presence (Intensity Map)
9. Asia Pacific Excluding Japan Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
9.2.1. China
9.2.2. India
9.2.3. Australia and New Zealand
9.2.4. ASEAN
9.2.5. Rest of APEJ
9.3. Market Size (US$ Mn) Forecast By Country, 2017-2027
9.3.1. China
9.3.2. India
9.3.3. Australia and New Zealand
9.3.4. ASEAN
9.3.5. Rest of APEJ
9.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
9.4.1. Streptococcus based
9.4.2. Legionella based
9.4.3. Chlamydophila based
9.4.4. Mycoplasma Pneumonia based
9.4.5. Viral Pneumonia based
9.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
9.5.1. Streptococcus based
9.5.2. Legionella based
9.5.3. Chlamydophila based
9.5.4. Mycoplasma Pneumonia based
9.5.5. Viral Pneumonia based
9.6. Drivers and Restraints: Impact Analysis
9.7. Market Attractiveness Analysis
9.7.1. By Country
9.7.2. By Product Type
9.8. Key Representative Market Participants
9.9. Key Participants Market Presence (Intensity Map)
10. Middle East and Africa Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
10.2.1. GCC Countries
10.2.2. South Africa
10.2.3. Rest of Middle East and Africa
10.3. Market Size (US$ Mn) Forecast By Country, 2017-2027
10.3.1. GCC Countries
10.3.2. South Africa
10.3.3. Rest of Middle East and Africa
10.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
10.4.1. Streptococcus based
10.4.2. Legionella based
10.4.3. Chlamydophila based
10.4.4. Mycoplasma Pneumonia based
10.4.5. Viral Pneumonia based
10.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
10.5.1. Streptococcus based
10.5.2. Legionella based
10.5.3. Chlamydophila based
10.5.4. Mycoplasma Pneumonia based
10.5.5. Viral Pneumonia based
10.6. Drivers and Restraints: Impact Analysis
10.7. Market Attractiveness Analysis
10.7.1. By Country
10.7.2. By Product Type
10.8. Key Representative Market Participants
10.9. Key Participants Market Presence (Intensity Map)
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
13. Competition Landscape
13.1. Market Share Analysis
13.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
13.2.1. Thermo Fisher Scientific Inc.
13.2.2. Alere Inc.
13.2.3. Quidel Corporation
13.2.4. Becton, Dickinson and Company
13.2.5. Meridian Bioscience, Inc.
13.2.6. Qiagen N.V.
13.2.7. bioMérieux SA
13.2.8. Bio-Rad Laboratories Inc.
13.2.9. Cardinal Health Inc.
13.2.10. Beckman Coulter Inc (Danaher Corporation)
14. Global Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027 By Region
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2016
14.2.1. North America
14.2.2. Latin America
14.2.3. Western Europe
14.2.4. Eastern Europe
14.2.5. Japan
14.2.6. Asia Pacific Excluding Japan
14.2.7. Middle East and Africa
14.3. Market Size (US$ Mn) Forecast By Region, 2017-2027
14.3.1. North America
14.3.2. Latin America
14.3.3. Western Europe
14.3.4. Eastern Europe
14.3.5. Japan
14.3.6. Asia Pacific Excluding Japan
14.3.7. Middle East and Africa
14.4. Market Attractiveness Analysis By Region
15. Global Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027, By Product Type
15.1. Introduction/Key Finding
15.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
15.2.1. Streptococcus based
15.2.2. Legionella based
15.2.3. Chlamydophila based
15.2.4. Mycoplasma Pneumonia based
15.2.5. Viral Pneumonia based
15.3. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
15.3.1. Streptococcus based
15.3.2. Legionella based
15.3.3. Chlamydophila based
15.3.4. Mycoplasma Pneumonia based
15.3.5. Viral Pneumonia based
15.4. Market Attractiveness Analysis By Product Type
16. Global Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027
16.1. Market Size and Y-o-Y Growth
16.2. Absolute $ Opportunity
17. Assumptions and Acronyms Used
18. Research Methodology
Pneumonia Diagnostic Market Reports - List of Tables
Table 01: North America Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 02: North America Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type
Table 03: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 04: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment
Table 05: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 06: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment
Table 07: Latin America Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 08: Latin America Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment
Table 09: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 10: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 11: Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment
Table 12: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 13: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment
Table 15: Global Pneumonia Diagnostics Market Size (US$ Mn) Forecast by Region, 2012–2017
Table 16: Global Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment
Pneumonia Diagnostic Market Reports - List of Figures
Figure 1: Global Pneumonia Diagnostics Market Value (US$ Mn), 2016-2027
Figure 2: Global Pneumonia Diagnostics Market Value Share By Product Type 2016 (A)
Figure 3: Global Pneumonia Diagnostics Market Value Share By Region 2016 (A)
Figure 4 : Leading Cause of Pneumonia based on Epidemiology
Figure 5: North America Pneumonia Diagnostics Market Value Share By Product Type (2017)
Figure 6: North America Pneumonia Diagnostics Market Value Share By Country (2017)
Figure 7: North America Pneumonia Diagnostics Market Value Share
Figure 8: North America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016
Figure 9: North America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 10: North America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Streptococcus-based Segment
Figure 11: North America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Streptococcus-based Segment
Figure 12: North America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Legionella-based Segment
Figure 13: North America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Legionella-based Segment
Figure 14: North America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Chlamydophila-based Segment
Figure 15: North America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Chlamydophila-based Segment
Figure 16: North America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Pneumonia-based Segment
Figure 17: North America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Pneumonia-based Segment
Figure 18: North America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Viral Pneumonia-based Segment
Figure 19: North America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Viral Pneumonia-based Segment
Figure 20: North America Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country
Figure 21: North America Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country
Figure 22: Western Europe Pneumonia Diagnostics Market Value Share By Product Type (2017)
Figure 23: Western Europe Pneumonia Diagnostics Market Value Share By Country (2017)
Figure 24: Western Europe Pneumonia Diagnostics Market Value Share
Figure 25: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016
Figure 26: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 27: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Streptococcus-based Segment
Figure 28: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Streptococcus-based Segment
Figure 29: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Legionella-based Segment
Figure 30: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Legionella-based Segment
Figure 31: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Chlamydophila-based Segment
Figure 32: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Chlamydophila-based Segment
Figure 33: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Pneumonia-based Segment
Figure 34: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Pneumonia-based Segment
Figure 35: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Viral Pneumonia-based Segment
Figure 36: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Viral Pneumonia-based Segment
Figure 37: Western Europe Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country
Figure 38: Western Europe Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country
Figure 39: Eastern Europe Pneumonia Diagnostics Market Value Share By Product Type (2017)
Figure 40: Eastern Europe Pneumonia Diagnostics Market Value Share By Country (2017)
Figure 41: Eastern Europe Pneumonia Diagnostics Market Value Share
Figure 42: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016
Figure 43: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 44: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Streptococcus-based Segment
Figure 45: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Streptococcus-based Segment
Figure 46: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Legionella-based Segment
Figure 47: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Legionella-based Segment
Figure 48: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Chlamydophila-based Segment
Figure 49: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Chlamydophila-based Segment
Figure 50: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Pneumonia-based Segment
Figure 51: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Pneumonia-based Segment
Figure 52: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Viral Pneumonia-based Segment
Figure 53: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Viral Pneumonia-based Segment
Figure 54: Eastern Europe Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country
Figure 55: Eastern Europe Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country
Figure 56: Latin America Pneumonia Diagnostics Market Value Share By Product Type (2017)
Figure 57: Latin America Pneumonia Diagnostics Market Value Share By Country (2017)
Figure 58: Latin America Pneumonia Diagnostics Market Value Share
Figure 59: Latin America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016
Figure 60: Latin America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 61: Latin America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Streptococcus-based Segment
Figure 62: Latin America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Streptococcus-based Segment
Figure 63: Latin America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Legionella-based Segment
Figure 64: Latin America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Legionella-based Segment
Figure 65: Latin America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Chlamydophila-based Segment
Figure 66: Latin America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Chlamydophila-based Segment
Figure 67: Latin America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Pneumonia-based Segment
Figure 68: Latin America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Pneumonia-based Segment
Figure 69: Latin America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Viral Pneumonia-based Segment
Figure 70: Latin America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Viral Pneumonia-based Segment
Figure 71: Latin America Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country
Figure 72: Latin America Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country
Figure 73: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Value Share By Product Type (2017)
Figure 74: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Value Share By Country (2017)
Figure 75: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Value Share By End User (2017)
Figure 76: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016
Figure 77: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 78: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Streptococcus-based Segment
Figure 79: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Streptococcus-based Segment
Figure 80: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Legionella-based Segment
Figure 81: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Legionella-based Segment
Figure 82: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Chlamydophila-based Segment
Figure 83: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Chlamydophila-based Segment
Figure 84: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Pneumonia-based Segment
Figure 85: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Pneumonia-based Segment
Figure 86: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Viral Pneumonia-based Segment
Figure 87: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Viral Pneumonia-based Segment
Figure 88: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country
Figure 89: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country
Figure 90: Japan Pneumonia Diagnostics Market Value Share By Product Type (2017)
Figure 91: Japan Pneumonia Diagnostics Market Value Share By End User (2017)
Figure 92: Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016
Figure 93: Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 94: Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Streptococcus-based Segment
Figure 95: Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Streptococcus-based Segment
Figure 96: Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Legionella-based Segment
Figure 97: Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Legionella-based Segment
Figure 98: Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Chlamydophila-based Segment
Figure 99: Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Chlamydophila-based Segment
Figure 100: Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Pneumonia-based Segment
Figure 101: Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Pneumonia-based Segment
Figure 102: Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Viral Pneumonia-based Segment
Figure 103: Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Viral Pneumonia-based Segment
Figure 104: Japan Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Product Type
Figure 105: Middle East & Africa Pneumonia Diagnostics Market Value Share By Product Type (2017)
Figure 106: Middle East & Africa Pneumonia Diagnostics Market Value Share By Country (2017)
Figure 107: Middle East & Africa Pneumonia Diagnostics Market Value Share By End User (2017)
Figure 108: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016
Figure 109: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 110: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Streptococcus-based Segment
Figure 111: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Streptococcus-based Segment
Figure 112: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Legionella-based Segment
Figure 113: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Legionella-based Segment
Figure 114: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Chlamydophila-based Segment
Figure 115: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Chlamydophila-based Segment
Figure 116: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Pneumonia-based Segment
Figure 117: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Pneumonia-based Segment
Figure 118: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Viral Pneumonia-based Segment
Figure 119: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Viral Pneumonia-based Segment
Figure 120: Middle East & Africa Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country
Figure 121: Middle East & Africa Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country
Figure 122: Global Pneumonia Diagnostic Market Share Analysis, 2016
Figure 123: Global Pneumonia Diagnostics Market Attractiveness Analysis by Region, 2017–2027
Figure 124: Global Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Product Type
Figure 125: Global Pneumonia Diagnostics Market Value Analysis and Forecast, 2016–2027 (US$ Mn)
Figure 126: Global Pneumonia Diagnostics Market Absolute $ Opportunity (US$ Mn), 2012–2016
Figure 127: Global Pneumonia Diagnostics Market Absolute $ Opportunity (US$ Mn), 2016–2027